Apyx Medical (APYX) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.54% |
| Dec 31, 2025 | 8.89% |
| Sep 30, 2025 | 1.25% |
| Jun 30, 2025 | -0.72% |
| Mar 31, 2025 | -1.52% |
| Dec 31, 2024 | -1.92% |
| Sep 30, 2024 | -3.59% |
| Jun 30, 2024 | -2.05% |
| Mar 31, 2024 | -0.18% |
| Dec 31, 2023 | 2.26% |
| Sep 30, 2023 | -7.62% |
| Jun 30, 2023 | -7.09% |
| Mar 31, 2023 | -11.57% |
| Dec 31, 2022 | -15.15% |
| Sep 30, 2022 | -14.02% |
| Jun 30, 2022 | -12.54% |
| Mar 31, 2022 | -11.81% |
| Dec 31, 2021 | -10.52% |
| Sep 30, 2021 | -15.71% |
| Jun 30, 2021 | 31.43% |
| Mar 31, 2021 | 33.16% |
| Dec 31, 2020 | 33.73% |
| Sep 30, 2020 | 34.93% |
| Jun 30, 2020 | 33.71% |
| Mar 31, 2020 | 35.38% |
| Dec 31, 2019 | 34.14% |
| Sep 30, 2019 | 43.95% |
| Jun 30, 2019 | 44.29% |
| Mar 31, 2019 | 45.62% |
| Dec 31, 2018 | 45.03% |
| Sep 30, 2018 | 50.62% |
| Jun 30, 2018 | -3.52% |
| Mar 31, 2018 | -4.51% |
| Dec 31, 2017 | 7.66% |
| Sep 30, 2017 | -0.63% |
| Dec 31, 2016 | 1.91% |
| Mar 31, 2016 | 1.94% |
| Dec 31, 2015 | 3.72% |
| Sep 30, 2015 | 5.71% |
| Jun 30, 2015 | 6.77% |
| Mar 31, 2015 | 7.31% |
| Dec 31, 2014 | -4.20% |
| Sep 30, 2014 | 3.10% |
| Dec 31, 2013 | 6.09% |